CRH Medical Corp (NYSEARCA:CRHM) had its target price dropped by investment analysts at Canaccord Genuity from $8.00 to $5.00 in a note issued to investors on Friday. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity’s target price would suggest a potential upside of 104.08% from the stock’s previous close.

A number of other analysts have also recently weighed in on CRHM. Zacks Investment Research cut shares of CRH Medical Corp from a “hold” rating to a “sell” rating in a report on Tuesday, April 11th. Scotiabank cut shares of CRH Medical Corp from an “outperform” rating to a “sector perform” rating in a report on Friday, July 14th. CIBC cut shares of CRH Medical Corp from a “sector outperform” rating to a “sector perform” rating in a report on Monday, July 17th. TD Securities cut shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a report on Tuesday, July 18th. Finally, Royal Bank Of Canada raised shares of CRH Medical Corp from a “sector perform” rating to an “outperform” rating in a report on Friday, July 21st. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $8.13.

Shares of CRH Medical Corp (NYSEARCA:CRHM) traded down 14.04% on Friday, reaching $2.45. 293,681 shares of the company’s stock traded hands. CRH Medical Corp has a 52 week low of $2.45 and a 52 week high of $9.25. The company has a 50 day moving average of $4.77 and a 200-day moving average of $6.37.

TRADEMARK VIOLATION NOTICE: This report was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/08/04/canaccord-genuity-lowers-crh-medical-corp-crhm-price-target-to-5-00.html.

A number of institutional investors have recently made changes to their positions in CRHM. Canada Pension Plan Investment Board acquired a new position in CRH Medical Corp during the second quarter valued at $683,000. TD Asset Management Inc. raised its position in CRH Medical Corp by 57.7% in the second quarter. TD Asset Management Inc. now owns 67,203 shares of the company’s stock valued at $382,000 after buying an additional 24,596 shares during the period. ARP Americas LLC raised its position in CRH Medical Corp by 119.6% in the second quarter. ARP Americas LLC now owns 28,642 shares of the company’s stock valued at $163,000 after buying an additional 15,600 shares during the period. Sei Investments Co. acquired a new position in CRH Medical Corp during the second quarter valued at $852,000. Finally, Mawer Investment Management Ltd. raised its position in CRH Medical Corp by 24.2% in the second quarter. Mawer Investment Management Ltd. now owns 4,742,491 shares of the company’s stock valued at $26,999,000 after buying an additional 924,540 shares during the period.

CRH Medical Corp Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (NYSEARCA:CRHM)

Receive News & Stock Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related stocks with our FREE daily email newsletter.